Clinical laboratories still face uncertainty and the difficult decision of whether to start the work needed to comply with the with Phase ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...
The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for ...
The Food and Drug Administration released a final rule on LDTs in April. Despite industry opposition, the agency has changed the regulations to classify diagnostics made by laboratories as medical ...
The FDA’s final rule for lab-developed tests (LDTs) is in litigation, and a district court decision may be shortly in the works.
The routine use of software to interpret the results of lab-developed tests (LDTs) leaves clinical labs in a complicated spot in 2025 thanks in no small part to an ongoing lawsuit over the U.S. FDA’s ...
On May 6, 2024, the FDA published its much-anticipated Final Rule on Lab-Developed Tests (LDTs). The Final Rule ended FDA’s longstanding policy of not actively regulating LDTs pursuant to its ...
In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results